In the continuing search for tests that will do a better job than the PSA test of defining clinically significant prostate cancer (as opposed to indolent disease) while it is still in its earliest possible stages, two new papers have provided information based on laboratory (not clinical studies). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: catenin, claudin, Diagnosis, ERG, risk, TMPRSS2 | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 